NCT03000543View on ClinicalTrials.gov

Novel Isotope Dilution Technique to Assess Vitamin A Status

NACompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions

Healthy InfantsInfants With an Inflammatory Condition

Interventions

BIOLOGICAL

Vaccine

Pentavalent vaccine. It is a combination of five different antigens (Hepatitis B (HBV)/ Haemophilus influenzae type b (HiB) / Tetanus-Diphtheria-whole cell Pertussis (TDwP)).

Trial Locations (2)

1212

Clinical Trail Unit (CTU), icddr,b., Dhaka

Shaikh Meshbahuddin Ahmad, Dhaka

All Listed Sponsors

collaborator

Newcastle University

OTHER

lead

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

NCT03000543 - Novel Isotope Dilution Technique to Assess Vitamin A Status | Biotech Hunter | Biotech Hunter